Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden
· Delayed Price · Currency is SEK 5.46
-0.14 (-2.50%)
Mar 10, 2026, 9:10 AM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 2.21 billion as of March 9, 2026. Its market cap has increased by 20.31% in one year.
Market Cap
2.21B
Enterprise Value
2.08B
Revenue
62.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.46
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 2.21B, an increase of 883.99%. That is a compound annual growth rate of 16.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diamyd Medical AB | 2.04B |
| Saniona AB | 2.01B |
| Vicore Pharma Holding AB | 2.75B |
| BioInvent International AB | 1.49B |
| Flerie AB | 2.87B |
| Hansa Biopharma AB | 3.02B |
| Genovis AB (publ.) | 1.10B |
| Cantargia AB | 1.02B |